Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2019  |  Volume : 32  |  Issue : 3  |  Page : 972-977

Human Chitinase-3-like Protein amarker of hepatic fibrosis in chronic hepatitis C virus infection


1 Department of Clinical Pathology, Faculty of Medicine, Menoufia University, Menoufia, Egypt
2 Department of Clinical Pathology, Etay El-Baroud Central Hospital, Behira, Egypt

Correspondence Address:
Hanan A Ahmed
Quesna, Menoufia
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/mmj.mmj_908_17

Rights and Permissions

Objective The aim was to evaluate the level of human chitinase-3-like protein (YKL-40) in patients with hepatitis C virus infection and observe its level in hepatic fibrosis. Background Hepatic fibrosis results from long-standing liver damage, and it represents a major health care burden worldwide. In recent years, there has been increasing interest in identifying and describing hepatic fibrosis through the use of noninvasive markers. The serum YKL-40 level has been evaluated as a noninvasive marker of various chronic inflammatory and fibrotic liver diseases, including chronic hepatitis C, chronic hepatitis B, and alcoholic liver disease. Participants and methods This study case–control study was carried out in Clinical Pathology Department, Faculty of Medicine, Menoufia University, in the period from September 2015 to November 2016. It was conducted on 77 patients with chronic hepatitis C infection and 10 age-matched and sex-matched healthy individuals as a control group. Serum level of YKL-40 was measured for all the participants of the study by enzyme-linked immune sorbent assay technique. Results Mean YKL-40 was lower among control than patient groups (28.0 ± 6.7 and 106.6 ± 38.8, respectively; P < 0.001). Moreover, YKL-40 was lower among mild fibrosis cases than marked fibrosis cases (98.1 ± 41.5 and 111.5 ± 36.6, respectively; P < 0.001). Conclusion There is increased serum level of YKL-40 in patients having liver fibrosis than in control group, and its level increases with the degree of fibrosis.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed43    
    Printed0    
    Emailed0    
    PDF Downloaded9    
    Comments [Add]    

Recommend this journal